The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); GE Healthcare (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Evolution of overall survival according to year of diagnosis (2008-2014) and subtypes, among 16703 metastatic breast cancer (MBC) patients included in the real-life "ESME" cohort.
 
Suzette Delaloge
No Relationships to Disclose
 
Monia Ezzalfani
No Relationships to Disclose
 
Veronique Dieras
Honoraria - AstraZeneca; Lilly; Pfizer; Roche
Consulting or Advisory Role - Merck; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Thomas Denis Bachelot
Honoraria - Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Marc Debled
No Relationships to Disclose
 
William Jacot
No Relationships to Disclose
 
Etienne Brain
Honoraria - AstraZeneca; Hospira; Janssen; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Hospira; OBI Pharma; Roche
Research Funding - Amgen (Inst); HalioDx (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pierre Fabre; Roche
 
Marie-Ange Mouret-Reynier
No Relationships to Disclose
 
Anthony Goncalves
No Relationships to Disclose
 
Florence Dalenc
No Relationships to Disclose
 
Anne Patsouris
No Relationships to Disclose
 
Jean-Marc Ferrero
No Relationships to Disclose
 
Christelle Levy
No Relationships to Disclose
 
Laurence Vanlemmens
No Relationships to Disclose
 
Claudia Lefeuvre
No Relationships to Disclose
 
Simone Mathoulin-Pélissier
No Relationships to Disclose
 
Thierry Petit
No Relationships to Disclose
 
Coralie Courtinard
No Relationships to Disclose
 
Christian Cailliot
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
 
David Pérol
Honoraria - Celgene; Janssen; Lilly; Roche
Consulting or Advisory Role - Roche
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)